Latest Breaking News On - Adria warren - Page 1 : comparemela.com

HMP Global's Clinical Pathways Congress + Cancer Care Business Exchange (CPC+CBEx) announces 2023 Congress Leadership

Convergence and Consolidation in Cancer Care

Foley Partners Adria Warren and Alexis Bortniker sit with Michael Kolodziej of ADVI Health about the upcoming Cancer Center Business Summit and the current convergence and consolidation in the oncology industry and what that means for the future of cancer care.

ACCC 47th Annual Meeting & Cancer Center Business Summit (AMCCBS): Positive Disruption In The COVID-19 ERA – Part 3 - Anti-trust/Competition Law

The ACCC 47 th Annual Meeting & Cancer Center Business Summit (AMCCBS) took place virtually, March 1-5. The Summit serves the prominent thought leadership forum and annual conference on matters of policy, business strategies, business models, hospital alignment, and best business practices in community oncology. The Next Wave in Oncology Transactions - Marketplace Considerations, Transaction Structures and Antitrust Foley Partner Adria Warren, along with Curtis Bernstein (Principal at Pinnacle Healthcare Consulting), Josh Eaves (Senior VP, Strategic Partnerships and Acquisitions at Alliance Oncology), and Brad Prechtl (CEO at American Oncology Network, LLC), explored the newest trends and opportunities available to community providers and hospitals in oncology transactions.

ACCC 47th Annual Meeting & Cancer Center Business Summit (AMCCBS): Positive Disruption in the COVID-19 ERA – Part 3 | Foley & Lardner LLP

ACCC 47th Annual Meeting & Cancer Center Business Summit (AMCCBS): Positive Disruption in the COVID-19 ERA – Part 2 | Foley & Lardner LLP

The ACCC 47 th Annual Meeting & Cancer Center Business Summit (AMCCBS) took place virtually, March 1-5. Through a combination of five-star panels and interactive drop-in sessions, attendees learned about key themes and trends in oncology today: telemedicine/telehealth, virtual care models and remote monitoring, including home therapy for chemo; cancer service line efficiency and revenue optimization; leveraging data; managing alternative payment models; employer-driven models and addressing disparities in cancer care; long-and short-term impacts of Covid-19 on oncology; clinical research; and current trends and the changing landscape in oncology transactions. You can also review our additional AMCCBS focused blogs on “Moving Forward Under the Biden Administration” by clicking the available link.